As attached.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Archit Organosys Limited's board, meeting on 23 May 2025, approved the audited standalone financial results for Q4 and FY ended 31 March 2025 along with the auditors' report and cash flow statement. Revenue from operations for FY25 rose to Rs. 12,559.92 lacs from Rs. 11,319.14 lacs in FY24, while profit after tax jumped to Rs. 505.11 lacs from Rs. 333.79 lacs. The company recommended a final dividend of Rs. 0.50 per equity share (5%) on a face value of Rs. 10, subject to shareholder approval. The board also appointed Mr. Ajay P Patel as the new Chief Financial Officer with immediate effect.
FY25 results show solid improvement with revenue up around 11% and PAT up over 51% YoY, reflecting margin expansion and absence of prior-year exceptional items. The 5% dividend and clean (unmodified) auditor opinion from G K Choksi & Co. are positive signals for shareholders, though cash and bank balances dropped sharply to Rs. 6.81 lacs from Rs. 482.30 lacs, indicating heavy deployment into inter-corporate loans and capex.